Journal of Mazandaran University of Medical Sciences
For Authors
Submission Instruction

Instruction to Authors

 | Post date: 2024/11/18 | 

Instructions for Authors
All manuscripts must be submitted online via http://jmums.mazums.ac.ir and the submission must include the following separate files:

  1. Cover letter
  2. Graphical abstract (to be provided at the acceptance stage)
  3. Manuscript (including title page)
  4. Manuscript (without title page)
  5. Copyright agreement
  6. Ethic Committe approval 
Cover letter
Submissions should include a covering letter addressed to the Editor-in-Chief, which must contain the following:
  • The manuscript title.
  • Names of all authors.
  • A statement confirming that the manuscript has not been published or submitted elsewhere.
  • A list of three potential referees.
  • Conflict of Interest Disclosure: Authors must disclose any financial interests or relationships that could be seen as influencing the research, such as funding sources, stock holdings, or other affiliations that might affect the interpretation of the study. This declaration will not automatically result in manuscript rejection but should be clearly stated for the editorial team's awareness
  • If applicable, details of any prior submissions and rejections from other journals.
Graphical Abstract:
Each submission must include a graphical abstract in English, designed to summarize the key findings of the article, which will be provided at the acceptance stage.

Manuscript Structure
Formatting:
Manuscripts should be typed double-spaced in Microsoft Word with clear margins on both sides. Tables and illustrations should be submitted on separate pages, and figures should be in JPEG or GIF format to ensure high-quality images in the online version of the journal. Avoid submitting tables as photographs.
The manuscript must include the following sections:
  1. Title Page:
  • Complete manuscript title
  • Names of all authors (with their highest academic qualifications)
  • Affiliations of all authors
  • Contact details of the corresponding author (including telephone, email, and fax)
  1. Abstract:
    Authors must provide a structured abstract in both English and Persian (500-600 words). The abstract should be divided into the following sections:
  • Background
  • Methods
  • Results
  • Conclusion
  • Keywords
    The abstract should be followed by 5-7 keywords selected from the Medical Subject Headings (MeSH) list. Ensure that the abstract accurately reflects the content of the manuscript.
  1. Introduction:
This section should provide a concise overview of the study's purpose and rationale, without reviewing the literature extensively or including data and conclusions.
  1. Materials and Methods:
Include detailed descriptions of the experimental or observational methods used, including:
  • Equipment or drugs used (with manufacturer details)
  • Drug dosages and administration routes
  • Participant demographics (e.g., age, sex, mean age ± standard deviation)
  • Statistical methods and data systems used
  1. Results:
 Results should be presented in the form of text, tables, and figures. Tables should not repeat the content already presented in the text; instead, refer to the table numbers in the narrative. Long manuscripts may benefit from subheadings to improve readability.
  1. Discussion:
 The discussion should focus on interpreting the findings, comparing them with previous research, and highlighting novel contributions. Avoid repeating detailed data that has already been presented. The conclusion should indicate whether the study's hypothesis has been supported, refuted, or remains inconclusive.
  1. Acknowledgments:
Acknowledgments should be included at the end of the manuscript, Authors should recognize individuals or organizations that contributed to the research but did not meet the criteria for authorship. This includes those who provided technical assistance, writing support, and financial or material resources. Full names of funding agencies should be listed, along with any relevant grant numbers. If no financial support was received, authors should state, "This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
  1. Author Contributions
Each author must be able to take public responsibility for the content of the manuscript and should meet the following criteria:
  • Substantial contributions to the conception or design of the work, or the acquisition, analysis, or interpretation of data;
  • Drafting the manuscript or revising it critically for important intellectual content;
  • Final approval of the version to be published; and
  • Agreement to be accountable for all aspects of the work, ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Each author must confirm their participation and responsibility as described above.
  1. Conflict of Interest
All authors must disclose any potential conflicts of interest that could be perceived as influencing the research, its interpretation, or the publication process. A conflict of interest could arise from financial relationships, personal relationships, professional connections, or other circumstances that may affect the objectivity of the research. Authors must include a statement of conflict of interest at the end of the manuscript, indicating any potential conflicts. If no conflict exists, authors should explicitly state "The authors declare no conflict of interest."
  1. References  
References must be numbered sequentially in the order of citation in the manuscript. Ensure all citations are accurate and complete, and verify them against the original documents. Only published works, or those "in press," should be cited. The reference list should be formatted as follows:
Journals:
 Russell FD, Coppell AL, Davenport AP. In vitro enzymatic processing of radio labeled big ET-1 in human kidney as a food ingredient. Biochem Pharmacol 1998; 55(5):697-701.
 Books:
 Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, et al, editors. Harrison's principles of internal medicine. 14th ed. New York: McGraw Hill, Health Professions Division; 1998.
Book chapter:
 Porter RJ, Meldrum BS. Antiepileptic drugs. In: Katzung BG, editor. Basic and clinical pharmacology. 6th ed. Norwalk, CN: Appleton and Lange; 1995. pp. 361-380.
Conference proceedings: 
Kimura J, Shibasaki H, editors. Recent advances in clinical neurophysiology. Proceedings of the 10th International Congress of EMG and Clinical Neurophysiology; 1995 Oct 15-19; Kyoto, Japan. Amsterdam: Elsevier; 1996.
Online journals: 
Morse SS. Factors in the emergence of infectious disease. Emerg Infect Dis] serial online] 1995 Jan- Mar;1(1):[24 screens]. Available from: URL:http://www/cdc/gov/ncidoc/EID/eid.htm. Accessed December 25, 1999. WWW site: Health on the net foundation. Health on the net foundation code of conduct (HONcode) for medical and health web sites. Available at: http://www.hon.ch/Conduct.html. Accessed June 30, 1998.
Tables and Figures 
  • Tables: Should be clearly constructed, numbered (1, 2, 3, etc.) in the order of their appearance in the text, and accompanied by detailed captions.
  • Figures: Must be submitted in acceptable digital formats (e.g., JPEG, TIFF) and should not be embedded within the manuscript text. Illustrations should be of high quality, clearly labeled with the author’s name, and properly oriented.
Abbreviations and Symbols 
  • Only standard abbreviations should be used.
  • These should not appear in the title or abstract.
  • The full term should precede the abbreviation when it is first used in the manuscript unless it is a standard unit of measurement.

Ethical Guidelines 
Ethical approval must be stated in the “Materials and Methods” section, including the name of the institutional review board that approved the study. Informed consent must be obtained from all human participants, and for minors, from their parents or legal guardians. For animal studies, compliance with National Institutes of Health (NIH) guidelines for the humane treatment of animals must be confirmed. Clinical trials must be registered with the Iranian Clinical Trials Center (IRCT) or other World Health Organization (WHO)-approved international registries.
Revisions  
Manuscripts may be returned to authors for revision, either for scientific content, length adjustments, or language corrections. The entire manuscript evaluation process, from submission to final decision (acceptance or rejection), is conducted exclusively through the journal’s submission system. However, all updates and changes regarding the manuscript’s status will also be communicated to the authors via the email address registered in the submission system.
Proofreading 
Authors will be given the opportunity to review proofs of their article before publication. Only typographical errors and minor changes can be made at this stage; major revisions are not allowed. The names of authors cannot be altered. Proofs must be returned within five days of receipt.
 Best Practices for Reporting Research in Scholarly Journals

As part of our commitment to ensuring high-quality, reproducible research, we encourage authors to follow the relevant reporting guidelines. These guidelines are designed to enhance the clarity, transparency, and rigor of research studies, regardless of study design. Please refer to the appropriate guidelines for your study type and ensure that you follow them as closely as possible when preparing your manuscript.
1. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses)
For systematic reviews and meta-analyses, use the PRISMA guidelines to ensure that key components such as the search strategy, study selection process, data extraction, and synthesis methods are clearly reported.
2. CONSORT (Consolidated Standards of Reporting Trials)
For randomized controlled trials (RCTs), authors should follow the CONSORT guidelines to ensure transparent reporting of trial design, methodology, statistical analysis, and participant flow.
3. STROBE (Strengthening the Reporting of Observational Studies in Epidemiology)
For observational studies (e.g., cohort, case-control, and cross-sectional studies), the STROBE guidelines should be used to ensure comprehensive reporting of study design, data collection, analysis, and interpretation.
4. STARD (Standards for Reporting Diagnostic Accuracy Studies)
For diagnostic accuracy studies, the STARD guidelines help ensure that the methods for measuring accuracy, such as sensitivity, specificity, and predictive values, are transparently reported
View: 15967 Time(s)   |   Print: 1284 Time(s)   |   Email: 0 Time(s)   |   0 Comment(s)

© 2025 CC BY-NC 4.0 | Journal of Mazandaran University of Medical Sciences

Designed & Developed by : Yektaweb